35163148|t|Soluble Endoglin Stimulates Inflammatory and Angiogenic Responses in Microglia That Are Associated with Endothelial Dysfunction.
35163148|a|Increased soluble endoglin (sENG) has been observed in human brain arteriovenous malformations (bAVMs). In addition, the overexpression of sENG in concurrence with vascular endothelial growth factor (VEGF)-A has been shown to induce dysplastic vessel formation in mouse brains. However, the underlying mechanism of sENG-induced vascular malformations is not clear. The evidence suggests the role of sENG as a pro-inflammatory modulator, and increased microglial accumulation and inflammation have been observed in bAVMs. Therefore, we hypothesized that microglia mediate sENG-induced inflammation and endothelial cell (EC) dysfunction in bAVMs. In this study, we confirmed that the presence of sENG along with VEGF-A overexpression induced dysplastic vessel formation. Remarkably, we observed increased microglial activation around dysplastic vessels with the expression of NLRP3, an inflammasome marker. We found that sENG increased the gene expression of VEGF-A, pro-inflammatory cytokines/inflammasome mediators (TNF-alpha, IL-6, NLRP3, ASC, Caspase-1, and IL-1beta), and proteolytic enzyme (MMP-9) in BV2 microglia. The conditioned media from sENG-treated BV2 (BV2-sENG-CM) significantly increased levels of angiogenic factors (Notch-1 and TGFbeta) and pERK1/2 in ECs but it decreased the level of IL-17RD, an anti-angiogenic mediator. Finally, the BV2-sENG-CM significantly increased EC migration and tube formation. Together, our study demonstrates that sENG provokes microglia to express angiogenic/inflammatory molecules which may be involved in EC dysfunction. Our study corroborates the contribution of microglia to the pathology of sENG-associated vascular malformations.
35163148	28	40	Inflammatory	Disease	MESH:D007249
35163148	104	127	Endothelial Dysfunction	Disease	MESH:D014652
35163148	184	189	human	Species	9606
35163148	190	223	brain arteriovenous malformations	Disease	MESH:D002538
35163148	225	230	bAVMs	Disease	MESH:D002538
35163148	293	336	vascular endothelial growth factor (VEGF)-A	Gene	22339
35163148	362	389	dysplastic vessel formation	Disease	MESH:D058426
35163148	393	398	mouse	Species	10090
35163148	457	479	vascular malformations	Disease	MESH:D054079
35163148	542	554	inflammatory	Disease	MESH:D007249
35163148	608	620	inflammation	Disease	MESH:D007249
35163148	643	648	bAVMs	Disease	MESH:D002538
35163148	713	725	inflammation	Disease	MESH:D007249
35163148	730	763	endothelial cell (EC) dysfunction	Disease	MESH:D055954
35163148	767	772	bAVMs	Disease	MESH:D002538
35163148	839	845	VEGF-A	Gene	22339
35163148	869	896	dysplastic vessel formation	Disease	MESH:D058426
35163148	1003	1008	NLRP3	Gene	114548
35163148	1086	1092	VEGF-A	Gene	7422
35163148	1098	1110	inflammatory	Disease	MESH:D007249
35163148	1145	1154	TNF-alpha	Gene	7124
35163148	1156	1160	IL-6	Gene	3569
35163148	1162	1167	NLRP3	Gene	114548
35163148	1169	1172	ASC	Gene	29108
35163148	1174	1183	Caspase-1	Gene	834
35163148	1189	1197	IL-1beta	Gene	3553
35163148	1224	1229	MMP-9	Gene	4318
35163148	1234	1237	BV2	CellLine	CVCL:0182
35163148	1289	1292	BV2	CellLine	CVCL:0182
35163148	1294	1297	BV2	CellLine	CVCL:0182
35163148	1361	1368	Notch-1	Gene	4851
35163148	1373	1380	TGFbeta	Gene	7040
35163148	1431	1438	IL-17RD	Gene	54756
35163148	1482	1485	BV2	CellLine	CVCL:0182
35163148	1635	1647	inflammatory	Disease	MESH:D007249
35163148	1683	1697	EC dysfunction	Disease	MESH:D055954
35163148	1788	1810	vascular malformations	Disease	MESH:D054079
35163148	Positive_Correlation	MESH:D058426	22339
35163148	Association	MESH:D007249	3569
35163148	Association	MESH:D007249	3553
35163148	Association	MESH:D007249	7124
35163148	Association	MESH:D007249	834
35163148	Association	MESH:D007249	29108

